Professor Bengt Glimelius awarded ESTRO Regaud Medal

Professor Bengt Glimelius has been awarded the ESTRO Regaud medal “in recognition of the enormous contribution he has made to the field of oncology, both in Europe and the worldwide community”.

His main research areas deal with tumour biology, gastrointestinal cancer, malignant lymphomas, radiotherapy and psychosocial care. He has an interest in better understanding the reasons why certain individuals get anal cancer and malignant lymphomas, how to best stage different tumours, and what influences the choice of therapy. His aim is to further develop clinical prognostic and predictive markers and study the short and long-term effects of various treatments in exploratory and randomised clinical trials.

Patient reported outcomes are of great importance in Bengt Glimelius’ scientific work. He has published more than 500 research articles and chapters in different textbooks within the research areas.